Healthcare & Biotech
Yemaachi Biotechnology
Diversifying precision cancer diagnostics and treatments
Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones…
- Diagnostics
- Biotech
- Therapeutics
- Website
- yemaachi.com
- Headquarters
- Accra, Greater Accra Region, Ghana
- Team size
- 11-50 people
- Founded
- 2021
- Demo
- 15 min demo
Similar companies
Cofactor GenomicsCofactor closes the precision medicine gap with predictive diagnostics
AlixiaTargeting the Tumor Ecosystem to address cancer drug resistance.
IsablCancer tests based on whole genome and transcriptome data.
Eris BiotechOur drugs engage the immune system to fight tumors
Equator TherapeuticsWe are developing a drug to burn calories and increase metabolism…
Origami Therapeutics, Inc.Oral drugs to halt neurodegeneration
Velorum TherapeuticsBreakthrough medicines unlocking the biology of heme
Sensible BiotechnologiesUnlocking the next generation of mRNA medicines